Arrowstreet Capital, Limited Partnership Acadia Pharmaceuticals Inc Transaction History

Arrowstreet Capital, Limited Partnership

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $1.14 Million - $1.84 Million	54,901 New	54,901 $1.14 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $794,897 - $1.66 Million	61,099 New	61,099 $861,000
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $152,622 - $335,439	-6,100 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $5.65 Million - $7.82 Million	-137,661 Reduced 95.76%	6,100 $326,000
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $5.19 Million - $8.12 Million	-142,373 Reduced 49.76%	143,761 $5.93 Million
Q2 2020 Aug 12, 2020	BUY	$39.26 - $52.73 $9.94 Million - $13.3 Million	253,134 Added 767.07%	286,134 $13.9 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $19.4 Million - $28.8 Million	-614,248 Reduced 94.9%	33,000 $1.39 Million
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $23.4 Million - $33.3 Million	647,248 New	647,248 $27.7 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.